Response to authors re commentary: Renewed controversy over cardiovascular risk with non-steroidal anti-inflammatory drugs
Int J Epidemiol
.
2018 Apr 1;47(2):675-676.
doi: 10.1093/ije/dyy051.
Authors
David Henry
1
,
Paulina Stehlik
1
,
Laura Rosella
2
Affiliations
1
Centre for Research in Evidence Based Practice, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, QLD, Australia.
2
Dalla Lana School of Public Health, University of Toronto, Toronto, ON, Canada.
PMID:
29618002
DOI:
10.1093/ije/dyy051
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Inflammatory Agents, Non-Steroidal*
Cardiovascular Diseases*
Humans
Risk Factors
Substances
Anti-Inflammatory Agents, Non-Steroidal